C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians

References

• . Pearson TA, Mensah GA, Alexander RW, ; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511
   PubMed Web of Science ®Google Scholar
• . Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med. 2006;119(2):166.e17–e28
   Google Scholar
• . Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812
   PubMed Web of Science ®Google Scholar
• . Dhingra R, Gona P, Nam BH, . C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med. 2007;120(12): 1054–1062
   PubMed Web of Science ®Google Scholar
• . Kaptoge S, Di Angelantonio E, Lowe G, ; Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132–140
   PubMed Web of Science ®Google Scholar
• . Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med. 2005;352(15):1611–1613
   PubMed Web of Science ®Google Scholar
• . Khera A, McGuire DK, Murphy SA, . Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46(3):464–469
   PubMed Web of Science ®Google Scholar
• . Spector TD, Hart DJ, Nandra D, . Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997;40(4):723–727
   PubMed Web of Science ®Google Scholar
• . Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999;100(7):713–716
   PubMed Web of Science ®Google Scholar
• . Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation. 2003;108(24):2993–2999
   Google Scholar
• . Rost NS, Wolf PA, Kase CS, . Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32(11):2575–2579
   PubMed Web of Science ®Google Scholar
• . Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97(5):425–458
   PubMed Web of Science ®Google Scholar
• . Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105(22):2595–2599
   PubMed Web of Science ®Google Scholar
• . Khera A, de Lemos JA, Peshock RM, . Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113(1):38–43
   Google Scholar
• . Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–843
   PubMed Web of Science ®Google Scholar
• . Danesh J, Wheeler JG, Hirschfield GM, . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387–1397
   PubMed Web of Science ®Google Scholar
• . Cushman M, Arnold AM, Psaty BM, . C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation. 2005;112(1):25–31
   PubMed Web of Science ®Google Scholar
• . Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611–619
   PubMed Web of Science ®Google Scholar
• . Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118(22): 2243–2251
   PubMed Web of Science ®Google Scholar
• . Ridker PM, Danielson E, Fonseca FA, . JUPITER Trial Study Group. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009;373(9670):1175–1182
   PubMed Web of Science ®Google Scholar
• . Genest J, McPherson R, Frolich J, . 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult: 2009 recommendations. Can J Cardiol. 2009;25(10):567–579
   PubMed Web of Science ®Google Scholar
• . Sabatine MS, Morrow DA, Jablonski KA, . Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115(12):1528–1536
   Google Scholar
• . Milazzo D, Biasucci LM, Luciani N, . Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol. 1999;84(4):459–461
   Google Scholar
• . Ridker PM, Cannon CP, Morrow D, . Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352(1):20–28
   PubMed Web of Science ®Google Scholar
• . Balk EM, Lau J, Goudas LC, . Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med. 2003;139(8):670–682
   PubMedGoogle Scholar
• . Ridker PM, Danielson E, Fonseca FA, ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207
   PubMed Web of Science ®Google Scholar
• . Baigent C, Blackwell L, Collins R, . Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860
   PubMed Web of Science ®Google Scholar
• . Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973–979
   PubMed Web of Science ®Google Scholar
• . Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkey B. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J. 1977;1(6055): 195–197
   PubMedGoogle Scholar
• . Hazleman B. Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Clin Exp Rheumatol. 2000;18(4 suppl 20):S29–S31
   Google Scholar
• . Vermeire S, Van Assche G, Rutgeerts P. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2(12):580–586
   PubMedGoogle Scholar
• . Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep. 2002;4(3):250–255
   PubMedGoogle Scholar
• . Pierce BL, Ballard-Barbash R, Bernstein L, . Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009;27(21):3437–3444
   PubMed Web of Science ®Google Scholar
• . O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer. 2000;37(1):36–40
   PubMed Web of Science ®Google Scholar
• . Chung YC, Chang YF. Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol. 2003;15(4):369–373
   Google Scholar
• . Mandalia V, Eyres K, Schranz P, Toms AD. Evaluation of patients with a painful total knee replacement. J Bone Joint Surg Br. 2008;90(3): 265–271
   Google Scholar
• . Austin MS, Ghanem E, Joshi A, Lindsay A, Parvizi J. A simple, cost-effective screening protocol to rule out periprosthetic infection. J Arthroplasty. 2008;23(1):65–68
   PubMed Web of Science ®Google Scholar
• . Póvoa P, Almeida E, Moreira P, . C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998;24(10):1052–1056
   PubMed Web of Science ®Google Scholar